Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

FDA Alerts Health Care Providers, Compounders, And Patients Of Dosing Errors With Compounded Injectable Semaglutide Products; Reports Of Adverse Events, Including Hospitalizations, Due To Overdoses From Miscalculation And Self-Administration Errors

Author: Benzinga Newsdesk | July 26, 2024 09:49am

- Reuters 

Posted In: NVO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist